XENE Financing Cash Flow
Xenon Pharmaceuticals Inc · Financing Cash Flow
XENE Financing Cash Flow
Latest reported$958.94Mperiod ending
XENE TTM Cash from Financing (-$4.39M → $958.94M)
TTM financing cash flow
High-resolution chart · PNG
XENE financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 958,936,000 | |
| 958,975,000 | |
| 117,113,000 | |
| 15,706,000 | |
| 13,346,000 | |
| 13,281,000 | |
| 12,130,000 | |
| 324,014,000 | |
| 353,522,000 | |
| 353,522,000 | |
| 353,522,000 | |
| 29,514,000 | |
| 705,000 | |
| 270,595,000 | |
| 278,471,000 | |
| 602,418,000 | |
| 606,477,000 | |
| 336,698,000 | |
| 447,543,000 | |
| 123,635,000 | |
| 121,284,617 | |
| 103,203,534 | |
| 86,952,534 | |
| 114,338,534 | |
| 111,948,917 | |
| 129,930,000 | |
| 27,518,000 | |
| 121,000 | |
| 77,532,000 | |
| 111,530,000 | |
| 111,591,000 | |
| 118,450,000 | |
| 41,021,000 | |
| 7,015,000 | |
| 7,070,000 | |
| 225,000 | |
| 24,059,000 | |
| 24,094,000 | |
| 23,964,000 | |
| 23,954,000 | |
| 147,000 | |
| 195,000 | |
| 278,000 | |
| 42,659,000 | |
| 42,063,000 | |
| 41,644,000 | |
| 41,124,000 | |
| -1,286,000 | |
| -3,420,000 | |
| -3,935,500 | |
| -4,391,000 | |
| -4,400,000 | |
| -1,697,000 |